Evidence map›Paper›PMID 19687006›Full record

ArticleThe Journal of biological chemistry2009

Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen.

Jennifer R Mastroianni, André J Ouellette

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 108 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Role of Defensins in Tumor Biology.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jennifer R MastroianniDepartment of Pathology and Laboratory Medicine, University of California, Irvine, California 92697-4800.
André J OuelletteDepartment of Pathology and Laboratory Medicine, University of California, Irvine, California 92697-4800; Department of Microbiology and Molecular Genetics, University of California, Irvine, California 92697-4800. Electronic address: andre.ouellette@keck.usc.edu.
University of California, Irvine · US

Funding

PEPTIDE EFFECTORS OF ENTERIC HOST DEFENSER01DK044632 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OUELLETTE, ANDRE J. · 1993 to 2010
$2.8M
STUDIES OF ALPHA-DEFENSINS IN PRIMATE INNATE IMMUNITYR01AI059346 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OUELLETTE, ANDRE J. · 2006 to 2010
$1.7M
PEPTIDE EFFECTORS OF ENTERIC HOST DEFENSER55DK044632 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI OUELLETTE, ANDRE J. · 1992 to 1992
–
NIAID NIH HHS AI059346NIAID NIH HHS R01 AI059346NIDDK NIH HHS DK044632NIDDK NIH HHS R01 DK044632
6 · The paper itself

Abstract

Paneth cells are a secretory epithelial lineage that release dense core granules rich in host defense peptides and proteins from the base of small intestinal crypts. Enteric alpha-defensins, termed cryptdins (Crps) in mice, are highly abundant in Paneth cell secretions and inherently resistant to proteolysis. Accordingly, we tested the hypothesis that enteric alpha-defensins of Paneth cell origin persist in a functional state in the mouse large bowel lumen. To test this idea, putative Crps purified from mouse distal colonic lumen were characterized biochemically and assayed in vitro for bactericidal peptide activities. The peptides comigrated with cryptdin control peptides in acid-urea-PAGE and SDS-PAGE, providing identification as putative Crps. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry experiments showed that the molecular masses of the putative alpha-defensins matched those of the six most abundant known Crps, as well as N-terminally truncated forms of each, and that the peptides contain six Cys residues, consistent with identities as alpha-defensins. N-terminal sequencing definitively revealed peptides with N termini corresponding to full-length, (des-Leu)-truncated, and (des-Leu-Arg)-truncated N termini of Crps 1-4 and 6. Crps from mouse large bowel lumen were bactericidal in the low micromolar range. Thus, Paneth cell alpha-defensins secreted into the small intestinal lumen persist as intact and functional forms throughout the intestinal tract, suggesting that the peptides may mediate enteric innate immunity in the colonic lumen, far from their upstream point of secretion in small intestinal crypts.

Indexed as

ColonIntestinal Mucosaalpha-DefensinsAmino Acid SequenceAnimalsAnti-Bacterial AgentsAntimicrobial Cationic Peptidesbeta-DefensinsHumansImmunity, InnateMiceMolecular Sequence DataPaneth CellsProtein IsoformsProtein PrecursorsSequence Alignmentalpha-DefensinsAnti-Bacterial AgentsAntimicrobial Cationic Peptidesbeta-DefensinscryptdinProtein IsoformsProtein Precursors

Identifiers

PMID19687006
PMCPMC2788835
OpenAlexW2070938244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.